
Edward Tenthoff
Stock Analyst at Piper Sandler
(4.39)
# 1,253
Out of 5,014 analysts
1270
Total ratings
39.2%
Success rate
9.3%
Average return
Main Sectors:
Stocks Rated by Edward Tenthoff
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CAMP Camp4 Therapeutics | Reiterated: Buy | $15 | $3.92 | +282.65% | 15 | Sep 29, 2026 | |
| DYN Dyne Therapeutics | Reiterated: Buy | $47 | $16.21 | +189.94% | 26 | Sep 29, 2026 | |
| CTMX CytomX Therapeutics | Reiterated: Buy | $12 | $2.75 | +336.36% | 11 | Sep 23, 2026 | |
| ARVN Arvinas | Reiterated: Buy | $20 | $7.50 | +166.67% | 34 | Sep 14, 2026 | |
| IBRX ImmunityBio | Reiterated: Buy | $12 | $8.83 | +35.90% | 8 | Sep 8, 2026 | |
| CAPR Capricor Therapeutics | Upgraded: Buy | $2 → $25 | $8.57 | +191.72% | 17 | Sep 1, 2026 | |
| ALNY Alnylam Pharmaceuticals | Reiterated: Buy | $489 | $254.07 | +92.47% | 101 | Aug 31, 2026 | |
| MESO Mesoblast | Reiterated: Buy | $35 → $39 | $14.87 | +162.27% | 16 | Aug 27, 2026 | |
| BMEA Biomea Fusion | Reiterated: Buy | $7 | $1.26 | +455.56% | 7 | Aug 14, 2026 | |
| FATE Fate Therapeutics | Reiterated: Buy | $6 → $8 | $2.38 | +236.13% | 38 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $2.08 | +284.62% | 6 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.11 | +260.36% | 9 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $1.17 | +412.82% | 7 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $15.42 | +55.64% | 3 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 | $11.74 | +215.16% | 19 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $77 | $203.46 | -62.15% | 112 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 | $25.00 | +32.00% | 47 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $126 | $66.25 | +90.19% | 75 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 | $56.00 | +96.43% | 67 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $7 | $1.21 | +480.91% | 9 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $1.62 | +85.19% | 30 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $64 | $18.82 | +240.06% | 23 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $4.85 | +209.60% | 25 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.65 | +142.42% | 21 | Jun 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $23 → $3 | $3.70 | -18.92% | 20 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $7 | $0.82 | +753.66% | 19 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $104 → $48 | $1.59 | +2,918.87% | 16 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 | $3.48 | +474.71% | 14 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $98 → $125 | $110.51 | +13.11% | 21 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $16.10 | +24.22% | 28 | Dec 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 → $2 | $25.51 | n/a | 13 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $0.8103 | n/a | 11 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $2.90 | n/a | 14 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.0004 | n/a | 20 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $52 | $3.65 | n/a | 14 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $0.5 | $14.58 | n/a | 4 | Aug 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $13 | $0.3077 | n/a | 10 | Apr 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3 → $0.3 | $0.0001 | n/a | 6 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $1 → $38 | $84.72 | n/a | 8 | Oct 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 → $44 | $15.20 | n/a | 3 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $13 | $1.85 | n/a | 14 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $160 → $60 | $15.42 | n/a | 15 | May 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $323 | $526.73 | n/a | 49 | Oct 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $9 | $1.15 | n/a | 9 | Sep 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 → $40 | $65.64 | n/a | 17 | Aug 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 | $58.65 | n/a | 34 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $309 → $250 | $970.66 | n/a | 21 | Jun 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 → $1.5 | $2.88 | n/a | 2 | Jun 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $5 → $2.5 | $1.10 | n/a | 5 | May 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $70 → $90 | $151.28 | n/a | 3 | Mar 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $0.000001 | n/a | 4 | Dec 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $5 → $60 | $3.14 | n/a | 6 | Sep 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 → $208 | $18.64 | n/a | 44 | Jun 21, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 | $13.90 | n/a | 1 | Jun 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $90 → $5 | $10.82 | n/a | 23 | Feb 28, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $0.00001 | n/a | 1 | Dec 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $19 | $40.61 | n/a | 5 | Nov 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 | $0.143 | n/a | 1 | Oct 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $4 → $0.1 | $0.0001 | n/a | 8 | Mar 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $5 | $0.0001 | n/a | 9 | Nov 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $557 | $750.51 | n/a | 35 | Sep 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $4 | $0.2025 | n/a | 6 | Feb 9, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1 | $5.08 | n/a | 5 | Sep 7, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $84.87 | n/a | 1 | Aug 18, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $1 | $0.000001 | n/a | 1 | Jul 9, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $20 | $45.89 | n/a | 1 | Jul 23, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $6 | $0.6745 | n/a | 1 | Mar 4, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.829 | n/a | 1 | Feb 20, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $2.5 | $11.51 | n/a | 1 | Dec 31, 2012 |
Camp4 Therapeutics
Sep 29, 2026
Reiterated: Buy
Price Target: $15
Current: $3.92
Upside: +282.65%
Dyne Therapeutics
Sep 29, 2026
Reiterated: Buy
Price Target: $47
Current: $16.21
Upside: +189.94%
CytomX Therapeutics
Sep 23, 2026
Reiterated: Buy
Price Target: $12
Current: $2.75
Upside: +336.36%
Arvinas
Sep 14, 2026
Reiterated: Buy
Price Target: $20
Current: $7.50
Upside: +166.67%
ImmunityBio
Sep 8, 2026
Reiterated: Buy
Price Target: $12
Current: $8.83
Upside: +35.90%
Capricor Therapeutics
Sep 1, 2026
Upgraded: Buy
Price Target: $2 → $25
Current: $8.57
Upside: +191.72%
Alnylam Pharmaceuticals
Aug 31, 2026
Reiterated: Buy
Price Target: $489
Current: $254.07
Upside: +92.47%
Mesoblast
Aug 27, 2026
Reiterated: Buy
Price Target: $35 → $39
Current: $14.87
Upside: +162.27%
Biomea Fusion
Aug 14, 2026
Reiterated: Buy
Price Target: $7
Current: $1.26
Upside: +455.56%
Fate Therapeutics
Aug 14, 2026
Reiterated: Buy
Price Target: $6 → $8
Current: $2.38
Upside: +236.13%
Aug 13, 2026
Reiterated: Buy
Price Target: $8
Current: $2.08
Upside: +284.62%
Aug 13, 2026
Reiterated: Buy
Price Target: $4
Current: $1.11
Upside: +260.36%
Aug 12, 2026
Reiterated: Buy
Price Target: $6
Current: $1.17
Upside: +412.82%
Aug 7, 2026
Reiterated: Buy
Price Target: $24
Current: $15.42
Upside: +55.64%
Aug 7, 2026
Reiterated: Buy
Price Target: $37
Current: $11.74
Upside: +215.16%
Aug 6, 2026
Reiterated: Buy
Price Target: $77
Current: $203.46
Upside: -62.15%
Aug 6, 2026
Reiterated: Buy
Price Target: $33
Current: $25.00
Upside: +32.00%
Aug 5, 2026
Reiterated: Buy
Price Target: $126
Current: $66.25
Upside: +90.19%
Aug 4, 2026
Reiterated: Buy
Price Target: $110
Current: $56.00
Upside: +96.43%
Jul 31, 2026
Reiterated: Buy
Price Target: $16 → $7
Current: $1.21
Upside: +480.91%
Jul 28, 2026
Reiterated: Buy
Price Target: $3
Current: $1.62
Upside: +85.19%
Jun 15, 2026
Reiterated: Buy
Price Target: $64
Current: $18.82
Upside: +240.06%
Jun 10, 2026
Reiterated: Buy
Price Target: $15
Current: $4.85
Upside: +209.60%
Jun 9, 2026
Reiterated: Buy
Price Target: $4
Current: $1.65
Upside: +142.42%
Jun 2, 2026
Downgraded: Sell
Price Target: $23 → $3
Current: $3.70
Upside: -18.92%
May 14, 2026
Reiterated: Buy
Price Target: $4 → $7
Current: $0.82
Upside: +753.66%
May 12, 2026
Rated: Buy
Price Target: $104 → $48
Current: $1.59
Upside: +2,918.87%
Feb 13, 2026
Reiterated: Hold
Price Target: $20
Current: $3.48
Upside: +474.71%
Dec 9, 2025
Reiterated: Buy
Price Target: $98 → $125
Current: $110.51
Upside: +13.11%
Dec 4, 2025
Reiterated: Buy
Price Target: $20
Current: $16.10
Upside: +24.22%
Apr 1, 2025
Reiterated: Buy
Price Target: $3 → $2
Current: $25.51
Upside: n/a
Mar 28, 2025
Reiterated: Buy
Price Target: $65
Current: $0.8103
Upside: n/a
Feb 7, 2025
Reiterated: Buy
Price Target: $60
Current: $2.90
Upside: n/a
Oct 23, 2024
Reiterated: Buy
Price Target: $5
Current: $0.0004
Upside: n/a
Nov 3, 2023
Reiterated: Buy
Price Target: $52
Current: $3.65
Upside: n/a
Aug 17, 2023
Reiterated: Hold
Price Target: $0.5
Current: $14.58
Upside: n/a
Apr 11, 2023
Reiterated: Buy
Price Target: $9 → $13
Current: $0.3077
Upside: n/a
Feb 23, 2023
Downgraded: Hold
Price Target: $3 → $0.3
Current: $0.0001
Upside: n/a
Oct 27, 2022
Upgraded: Buy
Price Target: $1 → $38
Current: $84.72
Upside: n/a
Aug 25, 2022
Reiterated: Buy
Price Target: $37 → $44
Current: $15.20
Upside: n/a
Aug 12, 2022
Reiterated: Buy
Price Target: $20 → $13
Current: $1.85
Upside: n/a
May 23, 2022
Reiterated: Buy
Price Target: $160 → $60
Current: $15.42
Upside: n/a
Oct 18, 2021
Reiterated: Buy
Price Target: $323
Current: $526.73
Upside: n/a
Sep 20, 2021
Reiterated: Buy
Price Target: $7 → $9
Current: $1.15
Upside: n/a
Aug 8, 2021
Reiterated: Buy
Price Target: $42 → $40
Current: $65.64
Upside: n/a
Jun 28, 2021
Reiterated: Buy
Price Target: $36
Current: $58.65
Upside: n/a
Jun 7, 2021
Reiterated: Hold
Price Target: $309 → $250
Current: $970.66
Upside: n/a
Jun 30, 2020
Reiterated: Buy
Price Target: $3 → $1.5
Current: $2.88
Upside: n/a
May 12, 2020
Downgraded: Hold
Price Target: $5 → $2.5
Current: $1.10
Upside: n/a
Mar 20, 2020
Upgraded: Buy
Price Target: $70 → $90
Current: $151.28
Upside: n/a
Dec 11, 2019
Reiterated: Buy
Price Target: $10
Current: $0.000001
Upside: n/a
Sep 5, 2019
Rated: Hold
Price Target: $5 → $60
Current: $3.14
Upside: n/a
Jun 21, 2019
Reiterated: Buy
Price Target: $200 → $208
Current: $18.64
Upside: n/a
Jun 4, 2019
Reiterated: Buy
Price Target: $32
Current: $13.90
Upside: n/a
Feb 28, 2019
Downgraded: Sell
Price Target: $90 → $5
Current: $10.82
Upside: n/a
Dec 12, 2018
Reiterated: Buy
Price Target: $30
Current: $0.00001
Upside: n/a
Nov 6, 2018
Reiterated: Buy
Price Target: $16 → $19
Current: $40.61
Upside: n/a
Oct 22, 2018
Initiated Coverage: Buy
Price Target: $23
Current: $0.143
Upside: n/a
Mar 12, 2018
Downgraded: Sell
Price Target: $4 → $0.1
Current: $0.0001
Upside: n/a
Nov 2, 2017
Reiterated: Buy
Price Target: $17 → $5
Current: $0.0001
Upside: n/a
Sep 11, 2017
Reiterated: Buy
Price Target: $557
Current: $750.51
Upside: n/a
Feb 9, 2017
Reiterated: Buy
Price Target: $5 → $4
Current: $0.2025
Upside: n/a
Sep 7, 2016
Reiterated: Buy
Price Target: $1
Current: $5.08
Upside: n/a
Aug 18, 2016
Reiterated: Buy
Price Target: $35
Current: $84.87
Upside: n/a
Jul 9, 2015
Downgraded: Hold
Price Target: $1
Current: $0.000001
Upside: n/a
Jul 23, 2013
Downgraded: Sell
Price Target: $20
Current: $45.89
Upside: n/a
Mar 4, 2013
Rated: Buy
Price Target: $6
Current: $0.6745
Upside: n/a
Feb 20, 2013
Reiterated: Buy
Price Target: $6
Current: $0.829
Upside: n/a
Dec 31, 2012
Rated: Buy
Price Target: $2.5
Current: $11.51
Upside: n/a